Moira L. Bode

1.4k total citations
44 papers, 1.1k citations indexed

About

Moira L. Bode is a scholar working on Organic Chemistry, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Moira L. Bode has authored 44 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Organic Chemistry, 22 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Moira L. Bode's work include Enzyme Catalysis and Immobilization (12 papers), HIV/AIDS drug development and treatment (10 papers) and Synthesis and Reactivity of Heterocycles (6 papers). Moira L. Bode is often cited by papers focused on Enzyme Catalysis and Immobilization (12 papers), HIV/AIDS drug development and treatment (10 papers) and Synthesis and Reactivity of Heterocycles (6 papers). Moira L. Bode collaborates with scholars based in South Africa, Netherlands and United States. Moira L. Bode's co-authors include Dean Brady, Perry T. Kaye, R. Ann Sheldon, Roger A. Sheldon, David Gravestock, Stephen C. Pelly, Amanda L. Rousseau, Charles B. de Koning, Christiaan W. van der Westhuyzen and Paul A. Steenkamp and has published in prestigious journals such as Chemical Society Reviews, Green Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Moira L. Bode

42 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moira L. Bode South Africa 16 629 482 102 81 81 44 1.1k
Somayeh Behrouz Iran 18 804 1.3× 308 0.6× 73 0.7× 52 0.6× 53 0.7× 97 1.1k
Matthew Whiting United Kingdom 14 1.0k 1.6× 514 1.1× 71 0.7× 48 0.6× 47 0.6× 21 1.2k
Junhua Tao United States 24 634 1.0× 1.1k 2.4× 182 1.8× 32 0.4× 126 1.6× 49 1.6k
Aaron B. Beeler United States 24 1.2k 1.9× 583 1.2× 169 1.7× 31 0.4× 112 1.4× 59 1.7k
Horacio F. Olivo United States 23 1.2k 1.9× 660 1.4× 69 0.7× 26 0.3× 89 1.1× 75 1.6k
Silvana Raić‐Malić Croatia 23 1.3k 2.0× 564 1.2× 51 0.5× 129 1.6× 64 0.8× 92 1.8k
Anne Routledge United Kingdom 18 478 0.8× 390 0.8× 53 0.5× 41 0.5× 69 0.9× 45 975
Constantinos G. Neochoritis Greece 23 1.4k 2.2× 691 1.4× 58 0.6× 54 0.7× 78 1.0× 77 1.8k
Nicholas A. Isley United States 21 1.1k 1.8× 396 0.8× 142 1.4× 85 1.0× 269 3.3× 23 1.5k

Countries citing papers authored by Moira L. Bode

Since Specialization
Citations

This map shows the geographic impact of Moira L. Bode's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moira L. Bode with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moira L. Bode more than expected).

Fields of papers citing papers by Moira L. Bode

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moira L. Bode. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moira L. Bode. The network helps show where Moira L. Bode may publish in the future.

Co-authorship network of co-authors of Moira L. Bode

This figure shows the co-authorship network connecting the top 25 collaborators of Moira L. Bode. A scholar is included among the top collaborators of Moira L. Bode based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moira L. Bode. Moira L. Bode is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akerman, Matthew P., et al.. (2024). Rationally modified SNX-class Hsp90 inhibitors disrupt extracellular fibronectin assembly without intracellular Hsp90 activity. RSC Medicinal Chemistry. 15(10). 3609–3615. 2 indexed citations
2.
Bode, Moira L., et al.. (2021). Comparing the greenness and sustainability of three routes to an HIV protease inhibitor intermediate. Green Chemistry. 23(9). 3334–3347. 15 indexed citations
3.
Sheldon, Roger A., et al.. (2021). Metrics of green chemistry: Waste minimization. Current Opinion in Green and Sustainable Chemistry. 33. 100569–100569. 116 indexed citations
4.
Bode, Moira L., et al.. (2021). Synthesis of phenanthridines via a novel photochemically-mediated cyclization and application to the synthesis of triphaeridine. Beilstein Journal of Organic Chemistry. 17. 2340–2347. 4 indexed citations
5.
Fernandes, Manuel A., et al.. (2021). Synthesis of 6-Membered-Ring Fused Thiazine-Dicarboxylates and Thiazole-Pyrimidines via One-Pot Three-Component Reactions. Molecules. 26(18). 5493–5493. 7 indexed citations
7.
Sheldon, R. Ann, Dean Brady, & Moira L. Bode. (2020). The Hitchhiker's guide to biocatalysis: recent advances in the use of enzymes in organic synthesis. Chemical Science. 11(10). 2587–2605. 211 indexed citations
8.
Bode, Moira L., et al.. (2020). Substrate Profiling of the Cobalt Nitrile Hydratase from Rhodococcus rhodochrous ATCC BAA 870. Molecules. 25(1). 238–238. 12 indexed citations
9.
Sayed, Yasien, et al.. (2020). Design, synthesis and biological evaluation of novel 2-(5-aryl-1H-imidazol-1-yl) derivatives as potential inhibitors of the HIV-1 Vpu and host BST-2 protein interaction. European Journal of Medicinal Chemistry. 190. 112111–112111. 11 indexed citations
10.
Vuuren, Sandy van, et al.. (2019). Design, synthesis and biological evaluation of imidazole and oxazole fragments as HIV-1 integrase-LEDGF/p75 disruptors and inhibitors of microbial pathogens. Bioorganic & Medicinal Chemistry. 28(1). 115210–115210. 22 indexed citations
11.
Westhuyzen, Christiaan W. van der, et al.. (2019). Bacterial nitrilases and their regulation. Applied Microbiology and Biotechnology. 103(12). 4679–4692. 15 indexed citations
12.
Westhuyzen, Christiaan W. van der, et al.. (2018). Dimethylformamide is a novel nitrilase inducer in Rhodococcus rhodochrous. Applied Microbiology and Biotechnology. 102(23). 10055–10065. 16 indexed citations
13.
Harmse, Leonie, et al.. (2016). Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity. European Journal of Medicinal Chemistry. 126. 353–368. 73 indexed citations
14.
Reynolds, Chevonne, Charles B. de Koning, Stephen C. Pelly, Willem A. L. van Otterlo, & Moira L. Bode. (2012). In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs). Chemical Society Reviews. 41(13). 4657–4657. 57 indexed citations
15.
Bode, Moira L., David Gravestock, Christiaan W. van der Westhuyzen, et al.. (2011). Imidazo[1,2-a]pyridin-3-amines as potential HIV-1 non-nucleoside reverse transcriptase inhibitors. Bioorganic & Medicinal Chemistry. 19(14). 4227–4237. 99 indexed citations
16.
Bode, Moira L., et al.. (2011). Enantioselective biocatalytic hydrolysis of β-aminonitriles to β-amino-amides using Rhodococcus rhodochrous ATCC BAA-870. Journal of Molecular Catalysis B Enzymatic. 76. 68–74. 24 indexed citations
17.
Brady, Dean, et al.. (2010). Defining a process operating window for the synthesis of 5-methyluridine by transglycosylation of guanosine and thymine. Journal of Biotechnology. 151(1). 108–113. 13 indexed citations
18.
Bode, Moira L., et al.. (2010). Structure elucidation and stereoselective total synthesis of pavettamine, the causal agent of gousiekte. Tetrahedron. 66(11). 2026–2036. 17 indexed citations
19.
Bode, Moira L., et al.. (2008). Extraction, isolation and NMR data of the tetraether lipid calditoglycerocaldarchaeol (GDNT) from Sulfolobus metallicus harvested from a bioleaching reactor. Chemistry and Physics of Lipids. 154(2). 94–104. 23 indexed citations
20.
Bode, Moira L., Fred van Rantwijk, & Roger A. Sheldon. (2003). Crude aminoacylase from aspergillus sp. is a mixture of hydrolases. Biotechnology and Bioengineering. 84(6). 710–713. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026